vs
Side-by-side financial comparison of ARGENX SE (ARGX) and Primoris Services Corp (PRIM). Click either name above to swap in a different company.
ARGENX SE is the larger business by last-quarter revenue ($2.5B vs $1.9B, roughly 1.3× Primoris Services Corp). ARGENX SE runs the higher net margin — 35.5% vs 2.8%, a 32.7% gap on every dollar of revenue. On growth, ARGENX SE posted the faster year-over-year revenue change (83.2% vs 6.7%). ARGENX SE produced more free cash flow last quarter ($322.4M vs $121.1M).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
Primoris Services Corporation is a publicly traded specialty construction and infrastructure company based in the United States, with a particular focus on pipelines for natural gas, wastewater and water. As of 2014 it was a Fortune 1000 company.
ARGX vs PRIM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.5B | $1.9B |
| Net Profit | $877.2M | $51.7M |
| Gross Margin | 89.5% | 9.4% |
| Operating Margin | 28.9% | 4.2% |
| Net Margin | 35.5% | 2.8% |
| Revenue YoY | 83.2% | 6.7% |
| Net Profit YoY | 1.3% | -4.2% |
| EPS (diluted) | $13.25 | $0.94 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.5B | $1.9B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | $1.8B | $1.9B | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | $1.4B | $1.7B | ||
| Q3 24 | — | $1.6B | ||
| Q2 24 | $901.9M | $1.6B | ||
| Q1 24 | — | $1.4B |
| Q4 25 | $877.2M | $51.7M | ||
| Q3 25 | — | $94.6M | ||
| Q2 25 | $414.8M | $84.3M | ||
| Q1 25 | — | $44.2M | ||
| Q4 24 | $865.6M | $54.0M | ||
| Q3 24 | — | $58.4M | ||
| Q2 24 | $-32.5M | $49.5M | ||
| Q1 24 | — | $18.9M |
| Q4 25 | 89.5% | 9.4% | ||
| Q3 25 | — | 10.8% | ||
| Q2 25 | 89.2% | 12.3% | ||
| Q1 25 | — | 10.4% | ||
| Q4 24 | 90.2% | 10.6% | ||
| Q3 24 | — | 12.0% | ||
| Q2 24 | 89.4% | 11.9% | ||
| Q1 24 | — | 9.4% |
| Q4 25 | 28.9% | 4.2% | ||
| Q3 25 | — | 6.3% | ||
| Q2 25 | 19.2% | 6.7% | ||
| Q1 25 | — | 4.3% | ||
| Q4 24 | 8.7% | 5.0% | ||
| Q3 24 | — | 6.0% | ||
| Q2 24 | -15.4% | 5.5% | ||
| Q1 24 | — | 3.1% |
| Q4 25 | 35.5% | 2.8% | ||
| Q3 25 | — | 4.3% | ||
| Q2 25 | 23.4% | 4.5% | ||
| Q1 25 | — | 2.7% | ||
| Q4 24 | 64.1% | 3.1% | ||
| Q3 24 | — | 3.5% | ||
| Q2 24 | -3.6% | 3.2% | ||
| Q1 24 | — | 1.3% |
| Q4 25 | $13.25 | $0.94 | ||
| Q3 25 | — | $1.73 | ||
| Q2 25 | $6.32 | $1.54 | ||
| Q1 25 | — | $0.81 | ||
| Q4 24 | $13.33 | $0.98 | ||
| Q3 24 | — | $1.07 | ||
| Q2 24 | $-0.55 | $0.91 | ||
| Q1 24 | — | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.5B | $535.5M |
| Total DebtLower is stronger | — | $469.9M |
| Stockholders' EquityBook value | $7.3B | $1.7B |
| Total Assets | $8.7B | $4.4B |
| Debt / EquityLower = less leverage | — | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.5B | $535.5M | ||
| Q3 25 | — | $431.4M | ||
| Q2 25 | $2.1B | $390.3M | ||
| Q1 25 | — | $351.6M | ||
| Q4 24 | $1.5B | $455.8M | ||
| Q3 24 | — | $352.7M | ||
| Q2 24 | $1.4B | $207.4M | ||
| Q1 24 | — | $177.6M |
| Q4 25 | — | $469.9M | ||
| Q3 25 | — | $486.0M | ||
| Q2 25 | — | $603.1M | ||
| Q1 25 | — | $612.0M | ||
| Q4 24 | — | $734.8M | ||
| Q3 24 | — | $903.7M | ||
| Q2 24 | $11.0M | $933.0M | ||
| Q1 24 | — | $951.7M |
| Q4 25 | $7.3B | $1.7B | ||
| Q3 25 | — | $1.6B | ||
| Q2 25 | $6.1B | $1.5B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | $5.5B | $1.4B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | $4.3B | $1.3B | ||
| Q1 24 | — | $1.2B |
| Q4 25 | $8.7B | $4.4B | ||
| Q3 25 | — | $4.6B | ||
| Q2 25 | $7.2B | $4.5B | ||
| Q1 25 | — | $4.2B | ||
| Q4 24 | $6.2B | $4.2B | ||
| Q3 24 | — | $4.2B | ||
| Q2 24 | $4.8B | $4.0B | ||
| Q1 24 | — | $4.0B |
| Q4 25 | — | 0.28× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.39× | ||
| Q1 25 | — | 0.42× | ||
| Q4 24 | — | 0.52× | ||
| Q3 24 | — | 0.67× | ||
| Q2 24 | 0.00× | 0.72× | ||
| Q1 24 | — | 0.76× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $323.3M | $142.9M |
| Free Cash FlowOCF − Capex | $322.4M | $121.1M |
| FCF MarginFCF / Revenue | 13.0% | 6.5% |
| Capex IntensityCapex / Revenue | 0.0% | 1.2% |
| Cash ConversionOCF / Net Profit | 0.37× | 2.76× |
| TTM Free Cash FlowTrailing 4 quarters | $594.5M | $340.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $323.3M | $142.9M | ||
| Q3 25 | — | $182.9M | ||
| Q2 25 | $361.8M | $78.5M | ||
| Q1 25 | — | $66.2M | ||
| Q4 24 | $41.9M | $298.3M | ||
| Q3 24 | — | $222.5M | ||
| Q2 24 | $-124.7M | $16.1M | ||
| Q1 24 | — | $-28.5M |
| Q4 25 | $322.4M | $121.1M | ||
| Q3 25 | — | $148.4M | ||
| Q2 25 | $356.6M | $45.3M | ||
| Q1 25 | — | $25.6M | ||
| Q4 24 | $40.9M | $270.0M | ||
| Q3 24 | — | $158.8M | ||
| Q2 24 | $-125.5M | $-8.1M | ||
| Q1 24 | — | $-38.9M |
| Q4 25 | 13.0% | 6.5% | ||
| Q3 25 | — | 6.8% | ||
| Q2 25 | 20.1% | 2.4% | ||
| Q1 25 | — | 1.6% | ||
| Q4 24 | 3.0% | 15.5% | ||
| Q3 24 | — | 9.6% | ||
| Q2 24 | -13.9% | -0.5% | ||
| Q1 24 | — | -2.8% |
| Q4 25 | 0.0% | 1.2% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | 0.3% | 1.8% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | 0.1% | 1.6% | ||
| Q3 24 | — | 3.9% | ||
| Q2 24 | 0.1% | 1.5% | ||
| Q1 24 | — | 0.7% |
| Q4 25 | 0.37× | 2.76× | ||
| Q3 25 | — | 1.93× | ||
| Q2 25 | 0.87× | 0.93× | ||
| Q1 25 | — | 1.50× | ||
| Q4 24 | 0.05× | 5.53× | ||
| Q3 24 | — | 3.81× | ||
| Q2 24 | — | 0.32× | ||
| Q1 24 | — | -1.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ARGX
Segment breakdown not available.
PRIM
| Energy Segment | $1.2B | 64% |
| Unit Price Contracts | $473.7M | 25% |
| Cost Reimbursable Contracts | $121.3M | 7% |
| Other | $74.9M | 4% |
